BioMarin Pharmaceutical has reported that its pivotal Phase III ENERGY 3 trial assessing BMN 401 in children aged one to...
SERB Pharmaceuticals has signed an agreement to acquire exclusive development and commercialisation rights to Idefirix from Hansa Biopharma for a...
Professor Rachid El Fatimy, dean of the Faculty of Medical Sciences and hospital general director at University Mohammed VI Polytechnic...
Boston Scientific has announced a $1.5bn investment to acquire a 34% equity stake in implants and procedural solutions developer MiRus.The...
Triveni Bio has dosed the first healthy volunteers in its Phase I study of TRIV-573, a half-life extended bispecific antibody...
Regeneron Pharmaceuticals has signed a $2.32bn deal with Parabilis Medicines to develop therapeutic candidates, with a focus on AHCs.The post...
PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior SI joint fusion, in the US.The post...
Regeneron Pharmaceuticals has reported that its Phase III trial assessing fianlimab and cemiplimab for metastatic melanoma failed to reach statistical...
The FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for two new indications in HER2-positive early breast cancer.The post FDA...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.